Earnings Feed
Start Free
Jazz Pharmaceuticals plc·4

Nov 4, 7:29 PM ET

O'Keefe Kenneth W 4

4 · Jazz Pharmaceuticals plc · Filed Nov 4, 2020

Insider Transaction Report

Form 4
Period: 2020-11-02
Jazz Pharmaceuticals plcJAZZ
O'Keefe Kenneth W
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    [F1]
    2020-11-02+22,249→ 29,667 total
  • Exercise/Conversion

    Phantom Stock

    [F1]
    2020-11-02−22,249→ 0 total
    From: 2020-11-02Exp: 2020-11-02→ Ordinary Shares (22,249 underlying)
Holdings

  • Ordinary Shares

    [F2]
    (indirect: By Trust)
    4,445
Footnotes (2)
  • [F1]On November 2, 2020, the Reporting Person's 22,249 phantom stock rights under the Issuer's Amended and Restated Directors Deferred Compensation Plan were settled for an equal number of the Issuer's ordinary shares.
  • [F2]Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
Signature
By: /s/Doris Choi, as attorney in fact For: Kenneth W O'Keefe|2020-11-04

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT